A Human Amniotic Cell Line Yielding High Titres of Human Fibroblast
Interferon (Accepted 10 June 1982) SUMMARY A line of human amniotic cells (UAC) was found to yield large amounts of fibroblast interferon (IFN-fl; 100 to 150 IU/103 cells) upon induction with Newcastle disease virus (NDV). UAC cells have a doubling time of about 24 h, and do not require foetal calf serum for growth or optimal IFN yield. The IFN produced was shown to be HuIFN-/~ by assaying it on homologous and heterologous cells, and by neutralization tests with specific antisera. It could be purified to a specific activity of 0-6 x 107 IU/mg protein by chromatography on Blue Sepharose. Addition of 8 ~tg poly(A +) RNA from NDV-induced UAC in 100 ~1 of reticulocyte lysate resulted in the production of 510 + 340 IU/ml of an IFN that was neutralized only by anti-HuIFN-/~ serum.
Although interferon (IFN) was discovered in 1957, by Isaacs & Lindenmann (1957) , purification to homogeneity of mouse (Mu) and human (Hu) IFN has not been achieved until recently, mainly because of the difficulty in obtaining large amounts of IFN. Mouse cell lines have been described which yield large amounts of IFN consisting of a mixture of MuIFN-~ and MuIFN-/~ . In the human system, on the other hand, IFN-/~ is essentially the only product of cultures of human primary fibroblasts (Billiau et al., 1979) , but the IFN yield is low [5 to 30 international units (IU)/103 cells] and the cells have a long doubling time (about 7 days). A more useful system for HuIFN-/~ production is the MG63 (osteosarcoma-derived) cell line, which produces large amounts of HulFN-/~ when induced with poly(rI), poly(rC) and metabolic inhibitors (Billiau et al., 1977) or with Newcastle disease virus (NDV) or Sendai virus (Meager et al., 1982) .
We describe here an amniotic cell line (UAC; supplied by Dr K. Cantell, Central Public Health Laboratory, Helsinki, Finland) which is widely used for IFN assay but is not known as a high producer of HuIFN-/L These cells have a short doubling time (24 h) and do not require addition of foetal calf serum (FCS) to the growth media. UAC cells were grown in Eagle's minimum essential medium (MEM) supplemented with 10 ~ newborn calf serum (NCS) (Flow Laboratories), 0.22~ NaHCO3, 100 units/ml penicillin and 100 Ixg/ml streptomycin. Sendai virus and NDV were grown on 10-day-old embryonated eggs. Vesicular stomatitis virus (VSV), Indiana strain, was propagated on monolayers of L929 cells. IFN titres were assayed by a method measuring the 50~ reduction of VSV plaque formation on UAC cells and by a microtitre assay based on the inhibition of VSV c.p.e, on UAC cells or on human primary embryo fibroblasts E1SM (a gift of A. Billiau, Rega Institute, Leuven, Belgium). Titrations were always carried out with an internal IFN standard, in turn calibrated against the NIH HulFN-B standard code 4023-902-527.
For IFN production, confluent (1-5 × l0 s to 2 x 10S/cm z) UAC cells were infected with Sendai virus or NDV at the m.o.i, indicated in Table 1 . After 1 h of adsorption, the virus inoculum was removed and MEM + 2~ NCS was added. In some experiments serum-free medium was added after virus adsorption, causing no significant falls in IFN titres. Pilot experiments indicated that IFN yields were maximal at 16 to 20 h (data not shown). Supernatants of induced cultures were therefore collected 20 h after virus inoculation, acidified with 6 M-HCI, kept for 5 days at 4 °C, and then neutralized with 6 M-NaOH and stored at -70 °C. In superinduction-type experiments, poly(rI), poly(rC) and cycloheximide were added instead of the virus. Actinomycin D was added 4 h later. Cultures were washed free of all compounds 2 h thereafter and fresh MEM + 2~ NCS added. IFN was harvested 20 h later.
As shown in Table 1 , both Sendal virus and 'superinduction' treatments were able to induce IFN in UAC cells, yet NDV induced the largest amounts of IFN (1.02 + 0-39 × 105) IU/ml; * IFN samples were diluted in MEM + 2% FCS to titres of 250 IU/ml. A 0.1 ml amount was mixed with the same volume of appropriate antisera or with an equivalent volume of MEM + 2% FCS, incubated for 1 h at 37 °C and for 1 h at 4 °C before titration of the mixture on E1SM cells in the microtitre assay. The antiserum against HulFN-c~, able to neutralize 5 × 105 IU of IFN-a, was used at a dilution of 5 x 10 -2. The antiserum against HulFN43, capable of neutralizing 10 IU of IFN-13 when diluted 106-fold, was used at a dilution of 2 x 10 -3.
I" HulFN-[3 was from superinduced E~SM cells.
mean of 70 titrations from 19 different inductions). Replicate cultures were trypsinized and the cells counted. In four experiments, it was found that UAC produced 100 to 150 IU/103 cells. Addition of sodium butyrate before and/or theophylline after virus induction did not enhance the production of IFN in this system. These treatments are known to increase IFN yields in several mouse (Adolf & Swetly, 1979; Slattery et al., 1980) and human (Morser et al., 1980) cell lines.
To determine whether the IFN produced by UAC was ofct-or fl-type, its antiviral activity was tested on bovine (MDBK) and human (E~SM) cells, since human leukocyte and fibroblast IFNs differ in their activity on heterologous cells. As expected for HuIFN-fl, UAC IFN was much more active on human (512 IU/ml) than bovine (8 IU/ml) cells. This conclusion was supported by antibody neutralization tests using HuIFN-ct and HuIFN-fl antisera. As shown in Table 2 , UAC-derived IFN was fully neutralized by a dilution of anti-HuIFN-fl that had no effect on HuIFN-ct. The addition of an anti-HulFN-ct serum did not neutralize UAC-derived IFN at all, indicating that it is mostly IFN-fl.
The specific activity of crude IFN preparations was approx. 104 IU/mg protein. Partial purification was carried out on a Blue Sepharose column according to Knight & Fahey (1981) . Briefly, UAC-derived IFN, concentrated 20-fold on an Amicon PM-10 membrane, was diluted with Sorensen's phosphate buffer pH 7.4 and NaC1 to final concentrations of 20 mM buffer and 1 M-NaC1, and passed down the column (0.5 x 9 cm). After washing the column with 200 ml of the same buffer, IFN was eluted with 50% ethylene glycol as a sharp peak. After a single chromatographic step, the specific activity was 0.6 × 107 IU/mg protein.
In view of the high IFN yields obtained, it was expected that UAC would contain abundant amounts of HulFN-fl mRNA. Total RNA was extracted from confluent UAC cells (grown in roller bottles) at different time intervals after NDV induction. Cell monolayers were washed with cold phosphate-buffered saline and then lysed in guanidine-6 M-HCI (Raj & Pitha, 1980) . Poly(A ÷) RNA, obtained by oligo(dT)-cellulose chromatography and precipitated three times with ethanol, was suspended in water at 1 btg/ktl. A 100 ~tl amount of rabbit reticulocyte lysate (New England Nuclear), added with 8 ~tg poly(A ÷) RNA extracted from UAC cells 9 h postinduction, was incubated at 37 °C. Diluted reaction mixtures were then tested for antiviral activity on EISM cells in the microtitre assay. The translation products of poly(A ÷) RNA from induced UAC cells had an IFN titre of 510 + 340 IU/ml (mean of five determinations). The antiviral activity present in the translation mixture was neutralized only by anti-HulFN-~ serum.
In conclusion, it appears that U amnion cells provide a useful system for studying the mechanisms regulating the induction and processing of HulFN-fl mRNA(s). Cloning of mRNA obtained from UAC should also be relatively easy, and could help in answering the question of whether there are one or multiple genes for HulFN-fl.
